BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1605603)

  • 1. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.
    Tomioka H; Saito H; Sato K; Yamane T; Yamashita K; Hosoe K; Fujii K; Hidaka T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):387-93. PubMed ID: 1605603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection.
    Emori M; Tomioka H; Sato K; Saito H
    Int J Antimicrob Agents; 1998 Apr; 10(1):59-65. PubMed ID: 9624545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice.
    Tomioka H; Sato K; Shimizu T; Sano C; Akaki T; Saito H; Fujii K; Hidaka T
    Antimicrob Agents Chemother; 1997 Feb; 41(2):357-62. PubMed ID: 9021192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method.
    Tomioka H; Saito H; Fujii K; Sato K; Hidaka T
    Antimicrob Agents Chemother; 1993 Jan; 37(1):67-70. PubMed ID: 8431020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice].
    Shimizu T; Tomioka H; Sato K; Akaki T; Ogasawara K; Kawahara S
    Kekkaku; 1999 Aug; 74(8):617-21. PubMed ID: 10487030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Profiles of expression of the therapeutic efficacy of KRM-1648 in mice infected with Mycobacterium avium complex at different challenge doses].
    Shimizu T; Ogasawara K; Sato K; Sano C; Tomioka H
    Kekkaku; 2001 May; 76(5):413-8. PubMed ID: 11449696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, in Mycobacterium intracellulare infection induced in mice].
    Saito H; Tomioka H; Sato K; Hidaka T
    Kekkaku; 1994 Feb; 69(2):59-63. PubMed ID: 8126989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the Chinese traditional medicine mao-bushi-saishin-to on therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, against Mycobacterium avium infection in mice.
    Shimizu T; Tomioka H; Sato K; Sano C; Akaki T; Dekio S; Yamada Y; Kamei T; Shibata H; Higashi N
    Antimicrob Agents Chemother; 1999 Mar; 43(3):514-9. PubMed ID: 10049260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered at the different periods of infection in Mycobacterium intracellulare--infected mice].
    Tomioka H; Sato K; Saito H; Hidaka T
    Kekkaku; 1993 Oct; 68(10):631-5. PubMed ID: 8255070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of bacterial regrowth at the sites of infection in Mycobacterium avium complex-infected mice during treatment with chemotherapeutic agents].
    Sato K; Tomioka H; Maw WW; Saito H
    Kekkaku; 1995 Dec; 70(12):673-8. PubMed ID: 8551714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
    Saito H; Tomioka H; Sato K; Kawahara S; Hidaka T; Dekio S
    Tuber Lung Dis; 1995 Feb; 76(1):51-8. PubMed ID: 7718848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoprophylaxis against Mycobacterium avium complex infection induced in mice].
    Saito H; Murakami K; Kobayashi K; Gidoh M; Hidaka T; Kwon HH
    Kekkaku; 1999 Sep; 74(9):677-81. PubMed ID: 10535281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of half-sized secretory leukocyte protease inhibitor and Chinese traditional medicines, yokuinin and mao-bushi-saishin-to, on therapeutic efficacies of benzoxazinorifamycin KRM-1648 against Mycobacterium avium complex infection induced in mice].
    Sato K; Shimizu T; Tomioka H; Kawahara S
    Kekkaku; 1998 Aug; 73(8):501-6. PubMed ID: 9780605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
    Ji B; Lounis N; Truffot-Pernot C; Grosset J
    Antimicrob Agents Chemother; 1996 Feb; 40(2):437-42. PubMed ID: 8834894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages.
    Sato K; Akaki T; Tomioka H
    J Antimicrob Chemother; 1998 Jan; 41(1):77-83. PubMed ID: 9511040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice].
    Akaki T; Sato K; Shimizu T; Tomioka H; Kawahara S
    Kekkaku; 1997 Aug; 72(8):491-7. PubMed ID: 9293712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.
    Bermudez LE; Kolonoski P; Young LS; Inderlied CB
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1844-8. PubMed ID: 7986018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits.
    Emori M; Saito H; Sato K; Tomioka H; Setogawa T; Hidaka T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):722-8. PubMed ID: 7684214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.
    Inderlied CB; Barbara-Burnham L; Wu M; Young LS; Bermudez LE
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1838-43. PubMed ID: 7986017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.